“The University of Washington School of Pharmacy and Washington State Pharmacy Association are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.”
ACPE #: 070-000-06-011-H04

This program is approved for 1.0 contact hour (.10 CEU) of continuing pharmacy education credit.

Emergency Department Pharmacy: A Step Toward the Future
September 27, 2006

Pharmacy Services have expanded over previous years to encompass many areas within Medical Centers; however, the Emergency Department (ED) has never been one of those to receive quality coverage. Proactive pharmacist involvement in the ED has proven to be an important value–added service, justified by clinical interventions, cost savings and increased revenue. At St. Joseph Medical Center, implementation of ED Pharmacists has benefited the Pharmacy and ED and illustrates the value of a new paradigm. This presentation will discuss the specific role of pharmacists in the ED and how the role relates to optimal medication / disease state management.

Objectives

1. Discuss the current trend of pharmacy services in the Emergency Department
2. Discuss the implementation and evolvement of Emergency Department Pharmacy Services at St. Joseph Medical Center
3. Investigate which patient populations benefit most from pharmacist intervention
4. Examine daily activities associated with drug / disease state management in the Emergency Department
5. Discuss the overall benefits and cost savings associated with Emergency Department Pharmacy Services

Faculty
Tony J. Casanova, PharmD
Emergency Department Pharmacist Specialist and
Emergency Department Clinical Pharmacist, St. Joseph Medical Center

Eric S. Wymore, PharmD
Emergency Department Clinical Pharmacist Specialist
St. Joseph Medical Center, Tacoma

Course Credit
This course is approved for 1.0 contact hour (.10 CEU) of ACPE accredited continuing pharmacy educaton credit. In order to receive ACPE Statement of Credit, participant must view entire presentation, download and complete the entire evaluation form and remit completed evaluation form along with $5 course fee to: UW Continuing Pharmacy Education, Box 357631, Seattle, WA 98195 or fax 206.685.9297. ACPE statements of credit will be mailed out within 1-3 weeks from date of receipt.

Faculty Disclosure
It is the policy of the UW School of Pharmacy to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. In accordance with this policy, educational content is developed and reviewed by a committee independent of grantor influence. Faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CPE program.

For speakers, significant relationships include receiving from a commercial company research grants, consultancies, honoraria and travel, or other benefits or having a self-managed equity interest in a company. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation or a presentation. The same applies when an unlabeled use of a commercial product or an investigational use not yet approved, is discussed during an educational activity, the accredited provider shall require the presenter to disclose the FDA status to the participants.

The speakers have indicated at the time of presentation that they had no relationships to disclose nor do they include a discussion of an unapproved/investigational or unlabeled use of commercial products for this presentation.